Core B: Developmental core

核心B:发展核心

基本信息

  • 批准号:
    10090663
  • 负责人:
  • 金额:
    $ 43.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-03 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

CORE B: Abstract/Summary The Developmental Core (Core B) supports the overall mission of the PMHARC through its services focused on training, mentoring, and management of the pilot projects program. During the current funding cycle, Core B, in partnership with the Administrative Core and the PMHARC Executive Committee (EC) established a rigorous, efficient strategy for the solicitation and review of high priority pilot research focused on mental illness and HIV/AIDS. The role of the pilot projects program within the PMHARC is central to its overall mission and provides the framework for the delivery of much of the Center's training and mentoring services. Pilots are expected to pair experienced investigators with early career or transitional investigators. All Cores are expected to assist with the development of pilot concepts and proposals and if selected for funding, provide services to the pilot investigators and their projects at no cost, adding real value to each pilot. During this first funding cycle, the PMHARC invested 10% of its annual total costs to support pilot projects and a total of 26 projects have been funded thus far with support of up to $40,000 each. In all of the Core's services, priority is given to early career investigators and investigators from underrepresented racial and ethnic groups. Forty-four early career and transitioning investigators have been engaged in pilot projects thus far, 21% are from racial and ethnic minority groups and 61% are women. To assist with the recruitment of participants for the pilot projects, the Core established the bi-weekly recruitment support group. As a result of the success of this group in assisting with recruitment for HIV/AIDS research beyond the pilots, this service transitioned to become an ongoing service of the Community Engagement Core. During the current funding cycle, the Developmental Core established the monthly PMHARC Journal Club that provides a forum for presentation and discussion of significant research focused on mental illness and HIV/AIDS. The Journal Club is also used as a venue for pilot investigators to present findings, receive feedback on interpretation of data, plan for publication and subsequent grant submissions, and practice presentation skills. Core B also led the development and implementation of the first city-wide conference designed to increase awareness of HIV research taking place in Philadelphia and to promote research collaborations. The serves as a clearinghouse for related seminars and trainings offered both on and off campus. During the next funding cycle, we will build on the success of the pilot projects program by working with seven other centers and institutes on campus to co-sponsor pilot projects, expanding the scientific reach of the PMHARC and providing increased funds for larger projects. As more pilots are completed, there will be an increased opportunity to promote publication of findings and grant applications. The Core will continue to facilitate mentoring relationships and collaborations and provide ongoing monitoring and evaluation of the pilot projects program.
核心B:摘要/摘要 发展核心(核心B)通过其重点服务来支持PMHARC的总体使命 关于试点项目计划的培训、指导和管理。在本供资周期内,核心 B、与行政核心和PMHARC执行委员会(欧委会)合作,设立了 严谨、高效的战略,征求和审查以精神疾病为重点的高度优先的试点研究 和艾滋病毒/艾滋病。试点项目方案在PMHARC内的作用对其总体任务和 为中心的大部分培训和指导服务的交付提供框架。飞行员是 预计将有经验的调查员与职业生涯早期或过渡期的调查员配对。所有核心都是 预计将协助制定试点概念和建议,如果被选中提供资金,将提供 免费为试点调查人员及其项目提供服务,为每个试点增加真正的价值。在这第一次 在资金周期内,PMHARC投入了年度总成本的10%来支持试点项目,总共投资了26 到目前为止,已为每个项目提供了高达40,000美元的资助。在Core的所有服务中,优先级是 提供给职业生涯初期的调查员和来自代表性不足的种族和民族群体的调查员。四十四岁 到目前为止,早期职业生涯和过渡时期的调查人员已经参与了试点项目,21%来自种族 和少数民族群体,61%是女性。协助招募试点参与者 在项目方面,核心设立了两周一次的征聘支助小组。由于这个团体的成功 在帮助招募飞行员以外的艾滋病毒/艾滋病研究方面,这一服务过渡为 社区参与核心的持续服务。在本供资周期内,发展中的 CORE建立了每月一次的PMHARC期刊俱乐部,该俱乐部提供了一个论坛,供演示和讨论 重要的研究集中在精神疾病和艾滋病毒/艾滋病上。杂志俱乐部也被用作飞行员的场地 调查人员提交调查结果,接收对数据解释的反馈,计划发布和 后续的拨款申请,并练习演示技巧。核心B也领导了开发和 执行旨在提高对艾滋病毒研究的认识的第一次全市会议 在费城,并促进研究合作。作为相关研讨会的信息交换中心 而且在校内外都提供培训。在下一个资金周期内,我们将在 试点项目计划,与校园内的其他七个中心和机构合作共同发起试点项目 项目,扩大PMHARC的科学影响范围,并为更大的项目提供更多资金。AS 更多的试点项目完成后,将有更多的机会促进成果的发布和拨款 申请。核心将继续促进指导关系和协作,并提供 对试点项目方案进行持续监测和评估。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID S METZGER其他文献

DAVID S METZGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID S METZGER', 18)}}的其他基金

Administrative Core A
行政核心A
  • 批准号:
    10891051
  • 财政年份:
    2023
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10197865
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10436808
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10654008
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10004224
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia
快速启动丁丙诺啡/纳洛酮以优化费城 MAT 的利用
  • 批准号:
    9896726
  • 财政年份:
    2018
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    7835556
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    7687184
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    8261981
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    8085908
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了